Search

Your search keyword '"Pore Forming Cytotoxic Proteins metabolism"' showing total 18 results

Search Constraints

Start Over You searched for: Descriptor "Pore Forming Cytotoxic Proteins metabolism" Remove constraint Descriptor: "Pore Forming Cytotoxic Proteins metabolism" Publisher academic press Remove constraint Publisher: academic press
18 results on '"Pore Forming Cytotoxic Proteins metabolism"'

Search Results

1. Pyroptosis-induced inflammation and tissue damage.

2. Artesunate protects pancreatic β-cells from streptozotocin-induced diabetes via inhibition of the NLRP3/caspase-1/GSDMD pathway.

3. Suppression of the caspase-1/GSDMD-mediated pyroptotic signaling pathway through dexamethasone alleviates corneal alkali injuries.

4. Preparation of rabbit polyclonal antibody against porcine gasdermin D protein and determination of the expression of gasdermin D in cultured cells and porcine tissues.

5. Farfantepenaeus gene-encoded antimicrobial peptides: Identification, molecular characterization and gene expression in response to fungal infections.

6. Interleukin-17A/F1 from Japanese pufferfish (Takifugu rubripes) stimulates the immune response in head kidney and intestinal cells.

7. Two Wnt genes regulate the expression levels of antimicrobial peptides during Vibrio infection in Macrobrachium nipponense.

8. Pore-forming toxins in Cnidaria.

10. Clostridial pore-forming toxins: powerful virulence factors.

11. Amino acid substitutions in LcrV at putative sites of interaction with Toll-like receptor 2 do not affect the virulence of Yersinia pestis.

12. Identification and characterisation of the Mpeg1 homologue in the South African abalone, Haliotis midae.

13. Midgut juice components affect pore formation by the Bacillus thuringiensis insecticidal toxin Cry9Ca.

14. Exogenous Yersinia pestis quorum sensing molecules N-octanoyl-homoserine lactone and N-(3-oxooctanoyl)-homoserine lactone regulate the LcrV virulence factor.

15. Further characterization of a type III secretion system (T3SS) and of a new effector protein from a clinical isolate of Aeromonas hydrophila--part I.

16. Biological characterization of a new type III secretion system effector from a clinical isolate of Aeromonas hydrophila-part II.

17. In vitro atrazine-exposure inhibits human natural killer cell lytic granule release.

18. Characterization of a cytotoxic CD57+ T cell subset from patients with pulmonary tuberculosis.

Catalog

Books, media, physical & digital resources